by Elizabeth Kissling | Dec 16, 2009 | Internet, Law/Legal, Media, Menopause, Pharmaceutical
That was Zoe Littlepage’s response to Pfizer’s request to a judge that her law firm remove this video press release about Pfizer’s malfeasance regarding cancer risk of Prempro, their menopause hormone therapy drug. The motion reads, in part,...
by Elizabeth Kissling | Dec 13, 2009 | Advertising, Law/Legal, Media, Menopause
There’s a pretty good essay in this weekend’s New York Times (online here Saturday, in print Sunday in the Business section) about how hard Big Pharma has worked to market menopause as an estrogen deficiency disease. In addition to discussion of...
by Elizabeth Kissling | Dec 11, 2009 | Girls, Health Care, Law/Legal, New Research, Pharmaceutical
Today I want to point to two important articles about women’s health from our friends at Women’s eNews: Yesterday, they published a story about Myriad Genetics and their firm grasp on the patents for diagnostics tests for BRCA1 and BRCA2 genes, which are...
by Elizabeth Kissling | Dec 8, 2009 | Law/Legal, Menopause, Pharmaceutical
Here’s one way that Canada shows some concern for risks to women’s health: the owner of a New Brunswick health food store was fined $7500 for smuggling a progesterone-laced cream from the U.S. The cream, called Aim Renewed Balance, is purported “to...
by Elizabeth Kissling | Nov 23, 2009 | Law/Legal, Menopause, Pharmaceutical
There are more than 10,000 lawsuits against Wyeth/Pfizer regarding the link between PremPro and breast cancer. There have been 12 verdicts so far, and juries have awarded money to the plaintiffs in ten of those cases. The latest was announced today, in Donna Kendall...
by Elizabeth Kissling | Nov 4, 2009 | Law/Legal, Menopause, Pharmaceutical
Even though the verdict regarding punitive damages awarded to Connie Barton in her suit against Prempro was sealed (as we wrote last week), the figure has leaked out. A Philadelphia jury awarded her $75 million in punitive damages, in addition to $3.7 million in...
